<DOC>
	<DOCNO>NCT01598597</DOCNO>
	<brief_summary>This pilot , non-interventional , observational , Web-based , prospective cohort study design collect self-reported safety effectiveness genetic data subject locally recurrent breast cancer ( BC ) metastatic breast cancer ( MBC ) , metastatic colorectal cancer ( MCRC ) , metastatic non-squamous non-small cell lung cancer ( MNSCLC ) , recurrent glioblastoma ( RGBM ) , metastatic renal cell cancer ( MRCC ) United States previously treat Avastin ( bevacizumab ) . The cohort compose male female subject diagnose locally recurrent BC MBC , MCRC , MNSCLC , RGBM , MRCC receive treatment bevacizumab combination chemotherapy , start prior 31 December 2012 . Participants self-referred study . They recruit online via number source , include involvement patient advocacy group , social medium tool , traditional medium , physician , event raise awareness study . After appropriate informed consent authorization obtain , data collect directly subject online survey . Participants contact electronically complete quarterly follow-up survey . The follow-up period 1 year respond baseline survey . DNA collection perform part study . DNA extract saliva , provide subject utilizing collection kit send participant at-home use .</brief_summary>
	<brief_title>An Observational Pilot Study Evaluating Feasibility Conducting Genome-Wide Association Studies Utilizing Subject Provided Information Subjects With Locally Recurrent MBC , MCRC , MNSCLC , RGBM MRCC Treated With Avastin ( Bevacizumab ) ( InVite )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Locally recurrent BC MBC , MCRC , MNSCLC , RGBM , MRCC patient treat treatment bevacizumab , start prior 31 December 2012 Ability read understand English Ability access use computer connect Internet Signed informed consent authorization form Residence United States At least 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>